AstraZeneca asthma drug Fasenra meets endpoints in Phase 3 trial
10th Sep 2020 09:00
(Sharecast News) - AstraZeneca said on Thursday that its Fasenra asthma drug met both co-primary endpoints in a phase III trial for patients with chronic rhinosinusitis with nasal polyps.
Read moreEurope midday: Stocks move higher as tech stocks bounce on Wall Street
9th Sep 2020 14:27
(Sharecast News) - Stocks in Europe are moving higher tracking a bounce on Wall Street with investors for the moment shrugging off news that AstraZeneca had paused the phase three clinical trials of its leading Covid-19 vaccine candidate.
Read moreJefferies says short-term correction in AstraZeneca may prove misplaced
9th Sep 2020 13:25
(Sharecast News) - Analysts at Jefferies reiterated their 'hold' recommendation for shares of AstraZeneca following the pharma giant's decision to press the pause button on its phase three clinical trial for the Covid-19 vaccine under development alongside the University of Oxford.
Read moreBioNTech and Pfizer announce positive result in pre-clinical trial for Covid-19 vaccine
9th Sep 2020 12:52
(Sharecast News) - One of the Covid-19 vaccine candidates being developed by German outfit BioNTech and Pfizer succeeded in pre-clinical challenge trials.
Read moreOxford Biomedica slumps as AstraZeneca vaccine trial halted
9th Sep 2020 08:31
(Sharecast News) - Oxford Biomedica shares slid on Wednesday on news that AstraZeneca and Oxford University's Covid-19 vaccine trial has been put on hold, as investors fretted over how this might affect the gene and cell therapy company's supply deal with the UK pharmaceuticals giant.
Read moreOxford/AstraZeneca Covid-19 drug trial paused as participant falls ill
9th Sep 2020 07:53
(Sharecast News) - Final trials for a potential coronavirus vaccine being developed by AstraZeneca and Oxford University, have been paused after a participant had an adverse reaction in the UK.
Read moreAstraZeneca pauses Covid-19 vaccine trial to review safety data
9th Sep 2020 01:13
(Sharecast News) - AstraZeneca paused the phase three clinical trial of the Covid-19 vaccine candidate that it was developing in conjunction with the University of Oxford, in response to a possible unexplained illness in one of the participants.
Read moreGlobal pharma bosses vow to put science first in race for Covid-19 vaccine
8th Sep 2020 11:52
(Sharecast News) - The bosses of nine of the world's largest pharmaceutical companies pledged to put science and safety first in the race to find a vaccine for Covid-19.
Read moreSector movers: Big pharma, support services pace gains
7th Sep 2020 14:57
(Sharecast News) - Big Pharma paced gains in London at the start of the week, led by shares in Dechra Pharmaceuticals after the veterinary drugs maker hiked its dividend payout following what it described as an "encouraging" start to its new financial year.
Read moreRussian vaccine candidate obtains positive peer reviews
4th Sep 2020 15:17
(Sharecast News) - Russia's Covid-19 vaccine candidate generated an immune response without any adverse side effects, according to a peer-reviewed study.
Read moreWHO does not expect mass Covid-19 vaccinations before mid-2021
4th Sep 2020 12:28
(Sharecast News) - The World Health Organization said on Friday it does not expect widespread vaccinations for Covid-19 until at least mid-2021.
Read moreUS CDC tells states to be ready to large-scale vaccination by 1 November
3rd Sep 2020 12:37
(Sharecast News) - America's Centers for Disease Control and Prevention in Atlanta has told state governments to make preparations for the large-scale distribution of a Covid-19 vaccine.
Read moreDHL warns of delivery issues for Covid-19n vaccine in poorer countries
3rd Sep 2020 10:25
(Sharecast News) - DHL warned on Thursday that two-thirds of the world's population is unlikely to have easy access to any Covid-19 vaccine requiring storage at freezing temperatures.
Read moreUS will not participate in international initiative to develop Covid-19 vaccine
2nd Sep 2020 09:12
(Sharecast News) - The US government said overnight that it will not participate in a global initiative to develop, manufacture and equitably distribute a vaccine for Covid-19 due to the World Health Organization's involvement.
Read moreAstraZeneca gets new Imfinzi approval, posts positive Farxiga results
1st Sep 2020 07:28
(Sharecast News) - AstraZeneca announced on Tuesday that 'Imfinzi', or durvalumab, has been approved in the European Union for the first-line treatment of adults with extensive-stage small cell lung cancer, in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin.
Read more